Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
C1-tetrahydrofolate synthase
-
C1-tetrahydrofolate synthetase
-
methylenetetrahydrofolate dehydrogenase 1-like
-
NAD-dependent methylenetetrahydrofolate dehydrogenase
-
10-formyl-THF synthetase
-
-
10-Formyltetrahydrofolate synthetase
C(1)-tetrahydrofolate synthase
-
a monofunctional 10-formyl-tetrahydrofolate synthetase lacking the 5,10-methylene-tetrahydrofolate dehydrogenase and 5,10-methenyl-tetrahydrofolate cyclohydrolase activities typically found in the trifunctional cytoplasmic proteins
C1-tetrahydrofolate synthase
-
-
formate-tetrahydrofolate ligase
-
-
-
-
formate:tetrahydrofolate ligase (ADP-forming)
-
-
-
-
Formyl-THF synthetase
-
-
-
-
Formyltetrahydrofolate synthetase
methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase-formyltetrahydrofolate synthetase
-
Synthetase, formyl tetrahydrofolate
-
-
-
-
Tetrahydrofolate formylase
-
-
-
-
Tetrahydrofolic formylase
-
-
-
-
10-Formyltetrahydrofolate synthetase
-
-
-
-
10-Formyltetrahydrofolate synthetase
-
-
10-Formyltetrahydrofolate synthetase
-
Formyltetrahydrofolate synthetase
-
-
-
-
Formyltetrahydrofolate synthetase
-
-
Formyltetrahydrofolate synthetase
-
MTHFD1
-
-
MTHFD1
trifunctional enzyme consisting of methylenetetrahydrofolate-dehydrogenase, methenyltetrahydrofolate-cyclohydrolase, and formyltetrahydrofolate synthetase
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
ATP + formate + tetrahydrofolate
ADP + phosphate + 10-formyltetrahydrofolate
(R,S)-tetrahydrofolate + ATP + formate
?
-
-
-
r
ATP + (6R,S)-tetrahydrofolate pteroylpentaglutamate
ADP + phosphate + 10-formyltetrahydrofolate pteroylpentaglutamate
-
-
-
-
?
ATP + (6R,S)-tetrahydrofolate pteroyltriglutamate
ADP + phosphate + 10-formyltetrahydrofolate pteroyltriglutamate
-
-
-
-
?
ATP + formate + (6R,S)-tetrahydrofolate monoglutamate
ADP + phosphate + 10-formyltetrahydrofolate monoglutamate
-
-
-
-
?
ATP + formate + tetrahydrofolate
?
-
two different physiological roles: 1. Functions anabolically in most organisms to activate formate via the forward reaction, and brings it into the one-carbon metabolic pool as N10-formyltetrahydrofolate, 2. In purine-fermenting bacteria the enzyme probably functions catabolically in the terminal step of the purine degradative pathway. This reaction may be responsible for ATP production in these organisms
-
-
?
ATP + formate + tetrahydrofolate
ADP + phosphate + 10-formyltetrahydrofolate
formate + ATP + tetrahydrofolate
10-formyltetrahydrofolate + ADP + phosphate
synthetase activity of MTHFD1
-
-
?
tetrahydrofolate + formate + ATP
10-formyltetrahydrofolate + ADP + phosphate
additional information
?
-
ATP + formate + tetrahydrofolate
ADP + phosphate + 10-formyltetrahydrofolate
-
-
?
ATP + formate + tetrahydrofolate
ADP + phosphate + 10-formyltetrahydrofolate
-
-
-
?
ATP + formate + tetrahydrofolate
ADP + phosphate + 10-formyltetrahydrofolate
trifuntional enzyme having 10-formyl-tetrahydrofolate synthetase, 5,10-methylene-tetrahydrofolate cyclohydrolase and 5,10-methylene-tetrahydrofolate dehydrogenase activity
-
?
ATP + formate + tetrahydrofolate
ADP + phosphate + 10-formyltetrahydrofolate
-
-
-
?
ATP + formate + tetrahydrofolate
ADP + phosphate + 10-formyltetrahydrofolate
-
-
-
?
ATP + formate + tetrahydrofolate
ADP + phosphate + 10-formyltetrahydrofolate
-
-
-
?
ATP + formate + tetrahydrofolate
ADP + phosphate + 10-formyltetrahydrofolate
-
-
-
?
ATP + formate + tetrahydrofolate
ADP + phosphate + 10-formyltetrahydrofolate
-
-
-
-
?
ATP + formate + tetrahydrofolate
ADP + phosphate + 10-formyltetrahydrofolate
-
-
-
?
tetrahydrofolate + formate + ATP
10-formyltetrahydrofolate + ADP + phosphate
-
monofunctional enzyme similar in structure to the cytoplasmatic trifunctional enzyme, dehydrogenase and cyclohydrolase activities are silent due to mutations of critical binding and catalytic residues
mitochondria also use formyltetrahydrofolate to produce formylmethionyl-tRNA to initiate protein synthesis
-
r
tetrahydrofolate + formate + ATP
10-formyltetrahydrofolate + ADP + phosphate
-
trifunctional enzyme exhibits synthetase, dehydrogenase and cyclohydrogenase activities
-
-
r
additional information
?
-
the enzyme may participate in the progression of colorectal cancer by conferring growth advantage
-
-
?
additional information
?
-
-
the enzyme may participate in the progression of colorectal cancer by conferring growth advantage
-
-
?
additional information
?
-
MTHFD1L directly interacts with the c-MYC proto-oncogene and basic helix-loop-helix (bHLH) transcription factor. MTHFD1L directly interacts with the MAGE family member D1 (MAGED)
-
-
-
additional information
?
-
-
enzyme is involved in the folate-mediated one-carbon metabolism, overview
-
-
?
additional information
?
-
(MTHFD1) is a trifunctional enzyme that interconverts tetrahydrofolate derivatives for nucleotide synthesis
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
ATP + formate + tetrahydrofolate
ADP + phosphate + 10-formyltetrahydrofolate
ATP + formate + tetrahydrofolate
?
-
two different physiological roles: 1. Functions anabolically in most organisms to activate formate via the forward reaction, and brings it into the one-carbon metabolic pool as N10-formyltetrahydrofolate, 2. In purine-fermenting bacteria the enzyme probably functions catabolically in the terminal step of the purine degradative pathway. This reaction may be responsible for ATP production in these organisms
-
-
?
ATP + formate + tetrahydrofolate
ADP + phosphate + 10-formyltetrahydrofolate
-
-
-
?
formate + ATP + tetrahydrofolate
10-formyltetrahydrofolate + ADP + phosphate
synthetase activity of MTHFD1
-
-
?
tetrahydrofolate + formate + ATP
10-formyltetrahydrofolate + ADP + phosphate
additional information
?
-
ATP + formate + tetrahydrofolate
ADP + phosphate + 10-formyltetrahydrofolate
-
-
?
ATP + formate + tetrahydrofolate
ADP + phosphate + 10-formyltetrahydrofolate
-
-
-
?
tetrahydrofolate + formate + ATP
10-formyltetrahydrofolate + ADP + phosphate
-
monofunctional enzyme similar in structure to the cytoplasmatic trifunctional enzyme, dehydrogenase and cyclohydrolase activities are silent due to mutations of critical binding and catalytic residues
mitochondria also use formyltetrahydrofolate to produce formylmethionyl-tRNA to initiate protein synthesis
-
r
tetrahydrofolate + formate + ATP
10-formyltetrahydrofolate + ADP + phosphate
-
trifunctional enzyme exhibits synthetase, dehydrogenase and cyclohydrogenase activities
-
-
r
additional information
?
-
the enzyme may participate in the progression of colorectal cancer by conferring growth advantage
-
-
?
additional information
?
-
-
the enzyme may participate in the progression of colorectal cancer by conferring growth advantage
-
-
?
additional information
?
-
MTHFD1L directly interacts with the c-MYC proto-oncogene and basic helix-loop-helix (bHLH) transcription factor. MTHFD1L directly interacts with the MAGE family member D1 (MAGED)
-
-
-
additional information
?
-
-
enzyme is involved in the folate-mediated one-carbon metabolism, overview
-
-
?
additional information
?
-
(MTHFD1) is a trifunctional enzyme that interconverts tetrahydrofolate derivatives for nucleotide synthesis
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Abortion, Habitual
Polymorphisms in MTHFR, MTHFD, and PAI-1 and recurrent miscarriage among North Indian women.
Alzheimer Disease
Chromosomal fragility associated with familial Alzheimer's disease.
Anemia, Megaloblastic
Update and new concepts in vitamin responsive disorders of folate transport and metabolism.
Atypical Hemolytic Uremic Syndrome
Update and new concepts in vitamin responsive disorders of folate transport and metabolism.
Carcinogenesis
Polymorphisms of MTHFD, plasma homocysteine levels, and risk of gastric cancer in a high-risk Chinese population.
Cleft Palate
Is MTHFD1 polymorphism rs 2236225 (c.1958G>A) associated with the susceptibility of NSCL/P? A systematic review and meta-analysis.
Colonic Neoplasms
A novel mitochondrial C1-tetrahydrofolate synthetase is upregulated in human colon adenocarcinoma.
Colonic Neoplasms
Integrated bioinformatics analysis identified MTHFD1L as a potential biomarker and correlated with immune infiltrates in hepatocellular carcinoma.
Colonic Neoplasms
Mthfd1 is a modifier of chemically induced intestinal carcinogenesis.
Colorectal Neoplasms
High expression of folate cycle enzyme MTHFD1L correlates with poor prognosis and increased proliferation and migration in colorectal cancer.
Colorectal Neoplasms
[Prediction of the efficacy of modified FOLFOX6 therapy according to the mRNA levels of thymidylate synthase (TS), excision repair cross-complementing-1 and -2( ERCC-1 and ERCC-2) and methylenetetrahydrofolate dehydrogenase( MTHFD) in the primary lesion of colorectal cancer].
Down Syndrome
Combined folate gene MTHFD and TC polymorphisms as maternal risk factors for Down syndrome in China.
Down Syndrome
Overexpression of C1-tetrahydrofolate synthase in fetal Down syndrome brain.
formate-tetrahydrofolate ligase deficiency
MTHFD1 formyltetrahydrofolate synthetase deficiency, a model for the MTHFD1 R653Q variant, leads to congenital heart defects in mice.
Heart Defects, Congenital
MTHFD1 formyltetrahydrofolate synthetase deficiency, a model for the MTHFD1 R653Q variant, leads to congenital heart defects in mice.
Heart Diseases
MTHFR c.1793G>A polymorphism is associated with congenital cardiac disease in a Chinese population.
Infections
Formate-tetrahydrofolate ligase is involved in the virulence of Streptococcus suis serotype 2.
Intestinal Neoplasms
Mthfd1 is a modifier of chemically induced intestinal carcinogenesis.
Laryngeal Neoplasms
Polymorphic variants of folate metabolism genes and the risk of laryngeal cancer.
Lymphoma, Non-Hodgkin
Polymorphisms in folate-metabolizing genes and risk of non-Hodgkin's lymphoma.
Neoplasm Metastasis
[Prediction of the efficacy of modified FOLFOX6 therapy according to the mRNA levels of thymidylate synthase (TS), excision repair cross-complementing-1 and -2( ERCC-1 and ERCC-2) and methylenetetrahydrofolate dehydrogenase( MTHFD) in the primary lesion of colorectal cancer].
Neoplasms
Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma.
Neoplasms
Folate enzymes in Ehrlich ascites carcinoma-bearing mice.
Neoplasms
Mitochondrial MTHFD isozymes display distinct expression, regulation, and association with cancer.
Neoplasms
Mthfd1 is a modifier of chemically induced intestinal carcinogenesis.
Neoplasms
MTHFD1L as a folate cycle enzyme correlates with prognostic outcome and its knockdown impairs cell invasive behaviors in osteosarcoma via mediating the AKT/mTOR pathway.
Neoplasms
The activities of the NAD-dependent methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase from ascites tumor cells are kinetically independent.
Neoplasms
[Polymorphic variants of folate metabolizing genes (C677T and A1298C MTHFR, C1420T SHMT1 and G1958A MTHFD) are not associated with the risk of breast cancer in West Siberian Region of Russia].
Neural Tube Defects
Molecular genetic analysis of the gene encoding the trifunctional enzyme MTHFD (methylenetetrahydrofolate-dehydrogenase, methenyltetrahydrofolate-cyclohydrolase, formyltetrahydrofolate synthetase) in patients with neural tube defects.
Severe Combined Immunodeficiency
Update and new concepts in vitamin responsive disorders of folate transport and metabolism.
Stomach Neoplasms
Polymorphisms of MTHFD, plasma homocysteine levels, and risk of gastric cancer in a high-risk Chinese population.
Tetralogy of Fallot
MTHFR rs1801133 C>T polymorphism is associated with an increased risk of tetralogy of Fallot.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.5
(6R,S)-tetrahydrofolate monoglutamate
-
above, recombinant enzyme, 30°C
0.0036
(6R,S)-tetrahydrofolate pteroylpentaglutamate
-
recombinant enzyme, 30°C
0.016
(6R,S)-tetrahydrofolate pteroyltriglutamate
-
recombinant enzyme, 30°C
0.333 - 0.364
tetrahydrofolate
additional information
additional information
-
steady-state kinetics, recombinant enzyme
-
0.0286
ATP
mutant R653Q
0.04
ATP
-
recombinant enzyme, 30°C, with substrate (6R,S)-tetrahydrofolate pteroyltriglutamate or (6R,S)-tetrahydrofolate pteroylpentaglutamate and formate
0.2
ATP
-
above, recombinant enzyme, 30°C, with substrate (6R,S)-tetrahydrofolate monoglutamate and formate
0.0367
formate
wild type
0.0371
formate
mutant R653Q
0.15
formate
-
recombinant enzyme, 30°C, with substrate (6R,S)-tetrahydrofolate pteroylpentaglutamate
0.44
formate
-
recombinant enzyme, 30°C, with substrate (6R,S)-tetrahydrofolate pteroyltriglutamate
11.8
formate
-
recombinant enzyme, 30°C, with substrate (6R,S)-tetrahydrofolate monoglutamate
0.333
tetrahydrofolate
mutant R653Q
0.364
tetrahydrofolate
wild type
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
23
synthetase activity of the wild type enzyme
23.8
synthetase activity of the mutant R653Q
additional information
100.2% activity of mutant R653Q after heating at 42°C for 90 min, in 7.5% glycerol and 0.35 mM folate pentaglutamate
additional information
102% activity of wild type enzyme after heating at 42°C for 90 min, in 7.5% glycerol and 0.35 mM folate pentaglutamate
additional information
57.4% activity of mutant R653Q, without adding of any cofactor, after heating at 42°C for 90 min, in 7.5% glycerol
additional information
72.3% activity of wild type enzyme, without adding of any cofactor, after heating at 42°C for 90 min, in 7.5% glycerol
additional information
80.5% activity of mutant R653Q after heating at 42°C for 90 min, in 7.5% glycerol, 1.2 mM MgCl, 0.6 mM ATP
additional information
88.2% activity of wild type enzyme after heating at 42°C for 90 min, in 7.5% glycerol, 1.2 mM MgCl, 0.6 mM ATP
additional information
enzyme knock-out cells are transfected with either wild type or R653Q mutant and their ability to synthesize purines is assessed by a 14C-formate incorporation assay, the cells expressing the R653Q variant incorporate only 74% of wild-type levels of formate into DNA, the R653Q protein appears to have a significant impact on cellular nucleotide metabolism
additional information
-
MTHFD1L is upregulated in colon adeno-carcinomas
additional information
-
overexpression of MTHFD1L in HEK-292 cells stimulates colony formation indicating that expression of this gene confers a growth advantage
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
metabolism
the folate cycle is an important metabolic pathway that fulfills a number of cancer-specific nutrient demands. Folate (folic acid), or vitamin B9, is commonly found in Western diets and dietary supplements. A 1-carbon (1C) unit from serine is transferred to tetrahydrofolate (THF) by serine hydroxymethyl transferases (SHMTs) to form 5,10-methylenetetrahydrofolate (CH2-THF). The 1C unit is then transferred from one position of THF to another, thus creating the folate cycle. The folate cycle is composed of the cytoplasmic and mitochondrial compartments. The cytoplasmic compartment is carried out by methylenetetrahydrofolate dehydrogenase, cyclohydrolase, and formyltetrahydrofolate synthetase 1 (MTHFD1), while the mitochondrial compartment is carried out by MTHFD2/2L and methylenetetrahydrofolate dehydrogenase 1-like (MTHFD1L). MTHFD1 is a cytoplasmic trifunctional enzyme with CH2-THF dehydrogenase (EC 1.5.1.5), 5,10-methenyl-tetrahydrofolate (CH+-THF, EC 3.5.4.9) cyclohydrolase, and 10-formyl-tetrahydrofolate (10-CHO-THF, EC 6.3.4.3) synthase activities
malfunction
knockdown of MTHFD1L impedes hepatocellular carcinoma (HCC) proliferation through induction of oxidative stress and ROS-associated cell cycle delay. In the MTHFD1L-knockdown HCC cells, the levels of TCA cycle metabolic intermediates derived from pyruvate/acetyl-CoA, including citrate, cis-aconitate, and isocitrate, decrease
malfunction
knockdown of MTHFD1L suppresses cell proliferation, colony formation, and tumorigenesis, while it induces apoptosis in oral squamous cell carcinoma (OSCC). Mechanistically, a microarray analysis shows that MTHFD1L suppresses c-MYC and activates p53 signaling by regulating the protein expression of TP53, GADD45A, FAS and JUN. the suppression of MTHFD1L affects c-MYC expression and thereby inhibits tumor cell proliferation and induces apoptosis. MTHFD1L knockdown may affect JUN expression through MAGED and induce cell apoptosis of the tumor.
malfunction
the elevation of oxidative stress through MTHFD1L knockdown or the use of methotrexate, an antifolate drug, sensitizes cancer cells to sorafenib, a targeted therapy for hepatocellular carcinoma
physiological function
the folate cycle, through transfer of a carbon unit between tetrahydrofolate and its derivatives in the cytoplasmic and mitochondrial compartments, produces other metabolites that are essential for cell growth, including nucleotides, methionine, and the antioxidant NADPH. Methylenetetrahydrofolate dehydrogenase 1-like (MTHFD1L) is the enzyme catalyzing the last step of the mitochondrial compartment generating formate, which subsequently can enter the cytoplasmic compartment. MTHFD1L plays critical roles in folate cycle maintenance and in support of cancer growth. MTHFD1L is transcriptionally activated by NRF2, a master regulator of redox homeostasis. MTHFD1L overexpression is closely associated with aggressive clinicopathological features of hepatocellular carcinoma (HCC) including the presence of tumor microsatellite formation, venous invasion, and more advanced tumor stages. MTHFD1L increased NADPH/NADP+ levels and reduced reactive oxygen species (ROS)
physiological function
the NAD-dependent methylenetetrahydrofolate dehydrogenase catalyzes the conversion of 10-formyltetrahydrofolate to formate in embryonic and adult mammalian mitochondria. Methylenetetrahydrofolate dehydrogenase 1-like (MTHFD1L) is a folate cycle enzyme that is involved in the development of various diseases including cancer. Immunohistochemical staining and Kaplan-Meier survival analysis indicate that MTHFD1L upregulation is associated with a poor prognosis in oral squamous cell carcinoma (OSCC). MTHFD1L contributes to the production of NADPH, which is sufficient in combating oxidative stress in OSCC. MTHFD1L directly interacts with the c-MYC proto-oncogene and basic helix-loop-helix (bHLH) transcription factor. MTHFD1L suppresses c-MYC and activates p53 signaling by regulating the protein expression of TP53, GADD45A, FAS and JUN. MTHFD1L directly interacts with the MAGE family member D1 (MAGED). MAGED enhances the phosphorylation of the JUN activator protein 1 (AP-1) transcription factor subunit and activates JUN. Regulation mechanism, overview
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
G1958A
-
the mutation is not associated with depression in postmenopausal women
R653Q
amino position 653 is located within the 10-formyltetrahydrofolate synthetase domain of the MTHFD1 protein affecting the supply of 10-formyltetrahydrofolate required for purine synthesis
R653Q
mutant enzyme has normal substrate affinity but a 36% reduction in half-life at 42°C, the mutation reduces the metabolic activity of MTHFD1 within cells: formate incorporation into DNA in murine Mthfd1 knockout cells transfected with Arg653Gln is reduced by 26%, compared to cells transfected with wild-type protein, the mutant may increase the risk for neural tube defects, under ideal storage and standard assay conditions, the synthetase activity of MTHFD1 is unaffected by the R653Q mutation
additional information
MTHFD1L-knockdown in cells is established by shRNA. Knockdown of MTHFD1L causes cell cycle delay
additional information
short hairpin RNA (shRNA)-induced MTHFD1L silencing, analysis of the effcets on the biological behavior of OSCC cells are assessed in vitro and in vivo, overview. Knockdown of MTHFD1L suppresses cell proliferation, colony formation, and tumorigenesis, while it induces apoptosis in oral squamous cell carcinoma (OSCC). Mechanistically, a microarray analysis shows that MTHFD1L suppresses c-MYC and activates p53 signaling by regulating the protein expression of TP53, GADD45A, FAS and JUN
additional information
-
the recombinant protein product (short isoform) of the alternatively spliced short transcript of the mitochondrial isozyme is not enzymatically active
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Schegg, K.M.; Welch jr., W.
The effect of nordihydroguaiaretic acid and related lignans on formyltetrahydrofolate synthetase and carboxylesterase
Biochim. Biophys. Acta
788
167-180
1984
Bos taurus, Cavia porcellus, Homo sapiens, Mus musculus, Rattus norvegicus
brenda
Buttlaire, D.H.
Purification and properties of formyltetrahydrofolate synthetase
Methods Enzymol.
66
585-599
1980
Clostridium acidi-urici, Clostridium cylindrosporum, Escherichia coli, Gallus gallus, Homo sapiens, Micrococcus aerogenes, Moorella thermoacetica, Neurospora crassa, Oryctolagus cuniculus, Ovis aries, Pigeon, Pisum sativum, Priestia megaterium, Proteus vulgaris, Saccharomyces cerevisiae, Spinacia oleracea, Veillonella parvula
brenda
Hum, D.W.; MacKenzie, R.E.
Expression of active domains of a human folate-dependent trifunctional enzyme in Escherichia coli
Protein Eng.
4
493-500
1991
Homo sapiens
brenda
Hol, F.A.; van der Put, N.M.; Geurds, M.P.; Heil, S.G.; Trijbels, F.J.; Hamel, B.C.; Mariman, E.C.; Blom, H.J.
Molecular genetic analysis of the gene encoding the trifunctional enzyme MTHFD (methylenetetrahydrofolate-dehydrogenase, methenyltetrahydrofolate-cyclohydrolase, formyltetrahydrofolate synthetase) in patients with neural tube defects
Clin. Genet.
53
119-125
1998
Homo sapiens
brenda
Prasannan, P.; Pike, S.; Peng, K.; Shane, B.; Appling, D.R.
Human mitochondrial C1-tetrahydrofolate synthase: gene structure, tissue distribution of the mRNA, and immunolocalization in Chinese hamster ovary calls
J. Biol. Chem.
278
43178-43187
2003
Homo sapiens (Q6UB35), Homo sapiens
brenda
Walkup, A.S.; Appling, D.R.
Enzymatic characterization of human mitochondrial C1-tetrahydrofolate synthase
Arch. Biochem. Biophys.
442
196-205
2005
Homo sapiens
brenda
Sugiura, T.; Nagano, Y.; Inoue, T.; Hirotani, K.
A novel mitochondrial C1-tetrahydrofolate synthetase is upregulated in human colon adenocarcinoma
Biochem. Biophys. Res. Commun.
315
204-211
2004
Homo sapiens (Q6UB35), Homo sapiens
brenda
Parle-McDermott, A.; Kirke, P.N.; Mills, J.L.; Molloy, A.M.; Cox, C.; OLeary, V.B.; Pangilinan, F.; Conley, M.; Cleary, L.; Brody, L.C.; Scott, J.M.
Confirmation of the R653Q polymorphism of the trifunctional C1-synthase enzyme as a maternal risk for neural tube defects in the Irish population
Eur. J. Hum. Genet.
14
768-772
2006
Homo sapiens (P11586)
brenda
Prasannan, P.; Appling, D.R.
Human mitochondrial C(1)-tetrahydrofolate synthase: Submitochondrial localization of the full-length enzyme and characterization of a short isoform
Arch. Biochem. Biophys.
481
86-93
2008
Homo sapiens, Rattus norvegicus
brenda
Slopien, R.; Jasniewicz, K.; Meczekalski, B.; Warenik-Szymankiewicz, A.; Lianeri, M.; Jagodzinski, P.P.
Polymorphic variants of genes encoding MTHFR, MTR, and MTHFD1 and the risk of depression in postmenopausal women in Poland
Maturitas
61
252-255
2008
Homo sapiens
brenda
Christensen, K.E.; Rohlicek, C.V.; Andelfinger, G.U.; Michaud, J.; Bigras, J.L.; Richter, A.; Mackenzie, R.E.; Rozen, R.
The MTHFD1 p.Arg653Gln variant alters enzyme function and increases risk for congenital heart defects
Hum. Mutat.
30
212-220
2009
Homo sapiens (P11586)
brenda
Christensen, K.E.; Mackenzie, R.E.
Mitochondrial methylenetetrahydrofolate dehydrogenase, methenyltetrahydrofolate cyclohydrolase, and formyltetrahydrofolate synthetases
Vitam. Horm.
79
393-410
2008
Homo sapiens, Saccharomyces cerevisiae (P07245), Saccharomyces cerevisiae (P09440)
brenda
Lee, D.; Xu, I.M.; Chiu, D.K.; Lai, R.K.; Tse, A.P.; Lan Li, L.; Law, C.T.; Tsang, F.H.; Wei, L.L.; Chan, C.Y.; Wong, C.M.; Ng, I.O.; Wong, C.C.
Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma
J. Clin. Invest.
127
1856-1872
2017
Homo sapiens (Q6UB35)
brenda
Zhao, L.; Cheng, Z.; Lu, Z.; Jin, J.
NAD-dependent methylenetetrahydrofolate dehydrogenase inhibits oral squamous cell carcinoma cell proliferation and promotes apoptosis
Transl. Cancer Res.
10
1457-1469
2021
Homo sapiens (Q6UB35)
brenda